Medicine and Dentistry
Allograft
8%
Amphotericin B
9%
Antifungal Agent
17%
Antifungal Therapy
8%
Aspergillosis
8%
Biological Marker
12%
Bronchoalveolar Lavage Fluid
8%
Calcofluor-White
8%
Central Nervous System
12%
Cerebrospinal Fluid
20%
Colony Forming Unit S
18%
Coronavirinae
23%
COVID-19
35%
Cross Reaction
9%
Cystic Fibrosis
10%
Diagnosis
72%
Disease
30%
Fluconazole
11%
Fungal Meningitis
15%
Fungemia
7%
Galactomannan
13%
Glucan
40%
Hazard Ratio
9%
Hematologic Malignancy
22%
Histopathology
8%
Human Immunodeficiency Virus
10%
Immunocompromised Patient
14%
Immunosuppressive Treatment
15%
In Vitro
16%
Infection
100%
Invasive Aspergillosis
20%
Lung Aspergillosis
29%
Lung Transplantation
16%
Matrix Assisted Laser Desorption Ionization Time of Flight Mass Spectrometry
8%
Meningitis
9%
Microbiome
9%
Mucormycosis
8%
Mycosis
13%
Nucleic Acid
10%
Odds Ratio
10%
Pathogen
43%
Pneumocystis Jirovecii
15%
Polymerase Chain Reaction
26%
Polymerase Chain Reaction
9%
Real-Time Polymerase Chain Reaction
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Sporotrichosis
15%
Systemic Mycosis
38%
Transplantation
30%
Treatment Response
11%
Immunology and Microbiology
Agar
10%
Antifungal Susceptibility
11%
Arthritis
41%
Aspergillus
19%
Aspergillus fumigatus
9%
Bacterial Cell Wall
18%
Bronchoalveolar Lavage Fluid
8%
Broth Dilution
15%
Candida
28%
Candida Albicans
12%
Candida Auris
30%
Cell Wall
31%
Cerebrospinal Fluid
15%
Chlamydiae
9%
Clinical Microbiology
16%
Collinsella aerofaciens
9%
Colony Forming Unit S
12%
Cryptococcus gattii
9%
Cryptococcus neoformans
15%
DNA Sequence
25%
Electrospray Mass Spectrometry
20%
Eubacterium
15%
Filamentous Fungus
11%
Filobasidiella
11%
Fusarium
9%
Immunocompromised Patient
28%
Immunofluorescence
13%
Infectious Agent
72%
Innate Immune System
15%
Kluyveromyces marxianus
15%
Lactobacillus
15%
Lung Transplantation
15%
Matrix-Assisted Laser Desorption-Ionization
34%
Mould
44%
Mouse
10%
Mycology
9%
Normal Human
9%
Organismal Interaction
9%
Peptidoglycan
12%
Pneumocystis Jiroveci
23%
Polymerase Chain Reaction
52%
Prevalence
11%
RNA Gene
10%
Solution and Solubility
12%
Superoxide
15%
Taxon
9%
Time-of-Flight Mass Spectrometry
34%
Tissue Distribution
15%
Transplant Procedure
16%
Viral Disease
9%
Keyphrases
1,3-Dichloropropene (1,3-D)
19%
3-D-glucan
19%
Antifungal Drugs
8%
Antifungal Susceptibility
12%
Arthritis
15%
Arthritogenic
16%
Aspergillosis
9%
Aurès
23%
Autopsy
9%
Bacteria Identification
9%
Bloodstream Infection
15%
Candida Auris
23%
Candida Kefyr
15%
Candidemia
14%
Cell Wall
18%
Central Nervous System
12%
Cerebrospinal Fluid
23%
Clinical Microbiology
15%
Confidence Interval
23%
COVID-19
11%
COVID-19-associated Pulmonary Aspergillosis
15%
Cryptococcosis
9%
Echinocandins
8%
Electrospray Ionization Mass Spectrometry
9%
Epidemiology
11%
Filamentous Molds
10%
Fungal Diagnosis
10%
Fungal Diseases
9%
Fungal Infection
16%
Fungal Pathogens
15%
Fungi
10%
Glucan
15%
Hematological Malignancies
13%
Histoplasmosis
23%
Immunocompromised Patients
16%
Invasive Aspergillosis
8%
Invasive Fungal Infection
16%
Laboratory Diagnosis
16%
Magnetofluidics
15%
Multidrug-resistant
25%
Non-endemic
10%
Pneumocystis Jirovecii
16%
Point-of-care Detection
15%
Progressive Disseminated Histoplasmosis
11%
Rapid Identification
8%
Risk Factors
10%
Solid Organ Transplant Recipients
28%
Typing Methods
11%
United States
10%
Voriconazole
9%